Contra Inhibrx is a United States biotechnology company associated with the Inhibrx corporate group. It focuses on the development of biologic therapeutic candidates and related intellectual property in the life sciences sector.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!